View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
HHS/FDA RIN: 0910-AA09 Publication ID: Fall 1995 
Title: Implementation of the Safe Medical Devices Act of 1990 
Abstract: The Safe Medical Devices Act of 1990 (SMDA), enacted November 28, 1990, was intended to assure marketed devices are safe and effective, FDA learns quickly of device problems, and has authority to remove defective devices from the market. The act directs or authorizes FDA to develop these regulations: Medical Device Reporting--This rule will require healthcare facilities and distributors to report deaths and serious injuries/illnesses related to medical devices. Medical Device Tracking--This regulation requires manufacturers to track certain devices to the user. Classification of Transitional Devices--FDA issued a notice to require submission of adverse safety and effectiveness data on transitional devices. FDA will now propose to keep each device in class III, or reclassify it in class I or II. Good Manufacturing Practices for Medical Devices--FDA proposed to add preproduction design validation in existing CGMP regulations. Exemption of Humanitarian Devices--The proposed rule gives procedures for applications for certain premarket review exemptions for humanitarian devices. ^PSummaries of Safety and Effectiveness for Premarket Notification--The final rule sets forth information to be included in data summaries on which substantial equivalence determinations are made. Recall of Medical Devices--A proposed rule sets forth procedures for using its authority to order device recalls and notifications. Reports of Removal and Corrections--FDA proposed procedures for manufacturers to report to FDA health-related market removals and corrections of devices. Civil Money Penalties--A final rule established procedures for a hearing to which persons are entitled before the imposition of civil money penalties. Procedural Changes in Medical Device Regulations--This final rule made revisions in regulations necessary because of procedural changes made by the SMDA. Premarket Review of Combination Products--FDA published a final rule establishing procedures for determining which FDA center will review premarket approval applications for products that are a combination of a device and a drug or biologic. 
Agency: Department of Health and Human Services(HHS)  Priority: Other Significant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Final Rule Stage 
CFR Citation: 21 CFR 860    21 CFR 820    21 CFR 807    21 CFR 803    21 CFR 17    21 CFR 812    21 CFR 7    21 CFR 814    21 CFR 821    21 CFR 861    21 CFR 895   
Legal Authority: PL 101-629 Safe Medical Devices Act of 1990   

Legal Deadline:
Action Source Description Date
Other  Statutory  for Medical Device Tracking for Exemption of Humanitarian Devices, etc. for Classification of Transitional Devices Notice  12/01/1991 
Final  Statutory  for Medical Device Tracking for Exemption of Humanitarian Devices, etc. for Classification of Transitional Devices Notice for Medical Device Tracking  08/28/1993 
NPRM  Statutory  for Medical Device Tracking  08/28/1991 
Final  Statutory  for Medical Device Tracking for Exemption of Humanitarian Devices, etc.  11/28/1991 
Timetable:
Action Date FR Cite
Final Action  To Be Determined    
Child RIN List:
RIN Title
0910-AE01 Assignment of Agency Component for Review of Premarket Applctns
0910-AD87 Civil Money Penalties
0910-AD94 Classification of Transitional Devices
0910-AD91 CGMPs for Medical Devices
0910-AD93 Exemption of Humanitarian Devices
0910-AD92 Medical Device Recall Authority
0910-AD90 Medical Device Reporting
0910-AD89 Medical Device Tracking
0910-AD99 Miscellaneous Procedural Changes in Medical Device Regulations
0910-AD97 Pre-Amendment Class III Devices (merged with 0905-AE34)
0910-AD95 Reports of Removals and Corrections of Medical Devices
0910-AD96 Safe Medical Devices Act of 1990; Implementation Plans
0910-AE00 Summaries of Safety & Effectiveness for Premarket Notification
0910-AD98 Temporary Suspension of a Premarket Approval Application
Additional Information: Previously reported under RIN 0905-AD59.
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Included in the Regulatory Plan: No 
Agency Contact:
Joseph M. Sheehan
Chief, Regulations Staff
Department of Health and Human Services
Food and Drug Administration
HFZ-215, Center for Devices and Radiological Health, HFZ-215, 1350 Piccard Drive,
Rockville, MD 20850
Phone:301 827-2974
Fax:301 594-4765
Email: joseph.sheehan@fda.hhs.gov